Novel STING-targeted PET radiotracer for alert and therapeutic evaluation of acute lung injury

Duo Xu,Fan Yang,Jiayao Chen,Tianxing Zhu,Fen Wang,Yitai Xiao,Zibin Liang,Lei Bi,Guolong Huang,Zebo Jiang,Hong Shan,Dan Li

DOI: https://doi.org/10.1016/j.apsb.2022.12.017

IF: 14.903

2022-12-29

Acta Pharmaceutica Sinica B

Abstract:Acute lung injury (ALI), as a common clinical emergency, is pulmonary edema and diffuse lung infiltration caused by inflammation. The lack of non-invasive alert strategy, resulting in failure to carry out preventive treatment, means high mortality and poor prognosis. Stimulator of interferon genes (STING) is a key molecular biomarker of innate immunity in response to inflammation, but there is still a lack of STING-targeted strategy. In this study, a novel STING-targeted PET tracer, [ 18 F]FBTA, was labeled with high radiochemical yield (79.7 ± 4.3%) and molar activity (32.5 ± 2.9 GBq/μmol). We confirmed that [ 18 F]FBTA has a strong STING binding affinity ( K d =26.86 ± 6.79 nmol/L) and can be used for PET imaging in ALI mice to alert early lung inflammation and to assess the efficacy of drug therapy. Our STING-targeted strategy also reveals that [ 18 F]FBTA can trace ALI before reaching the computed tomography (CT) diagnostic criteria, and demonstrates its better specificity and distribution than [ 18 F]fluorodeoxyglucose ([ 18 F]FDG).

pharmacology & pharmacy